Business Daily Media

ACN Business

Eisai's Equfina 50mg Tablets (Safinamide Mesilate) Launched in Japan

  • Written by ACN Newswire - Press Releases


TOKYO, Nov 20, 2019 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has launched the Equfina 50mg TABLETS (safinamide mesilate, "Equfina") for the indication of improvement of the wearing-off phenomenon in patients with Parkinson's disease under treatment with a drug containing levodopa in Japan.

Manufacturing and marketing approval

Read more //?#

Writers Wanted

Content & Technology Connecting Global Audiences

More Information - Less Opinion